N-(5-Methylisoxazol-3-yl)-4-nitrobenzenesulfonamide

Catalog No. :
ACGITM178
CAS No. :
29699-89-6
Molecular Formula :
C10H9N3O5S
Molecular Weight :
283.27

IUPAC Name:N-(5-methylisoxazol-3-yl)-4-nitrobenzenesulfonamide

N-(5-Methylisoxazol-3-yl)-4-nitrobenzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$124.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(5-Methylisoxazol-3-yl)-4-nitrobenzenesulfonamide
IUPAC NameN-(5-methylisoxazol-3-yl)-4-nitrobenzenesulfonamide
MDL No.MFCD01068800
Molecular FormulaC10H9N3O5S
Molecular Weight283.27
SMILESO=S(C1=CC=C([N+]([O-])=O)C=C1)(NC2=NOC(C)=C2)=O
InChI KeyXHJLDAHBWWMCRZ-UHFFFAOYSA-N
Synonym4-Nitro Sulfamethoxazole;N-(5-methyl-3-isoxazolyl)-4-nitrobenzenesulfonamide;Sulfamethoxazole 4-Nitro;Benzenesulfonamide, N-(5-methyl-3-isoxazolyl)-4-nitro-;Modafinil Impurity 7-d10;4-Nitro Sulfamethoxazole/Sulfamethoxazole 4-Nitro Impurity/N-(5-Methylisoxazol-3-yl)-4-nitrobenzenesulfonamide;Sulfamethoxazole Impurity 3;Sulfamethoxazole-NO
CAS No.29699-89-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACGITM178 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOULY350 route compound structure diagram
    ACOULY3501072-67-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGITM178 route product structure diagram
    ACGITM17829699-89-6
Inquiry

2. ACGITM178 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGITM178 route product structure diagram
    ACGITM17829699-89-6
Inquiry

Comments (0)